Abiopharma

🔍 MAYER MARISSA A (Director)

Company: Hilton Worldwide Holdings Inc. (HLT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 115 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,044.99 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By irrevocable trust | shares_owned_after: 716.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By revocable trusts | shares_owned_after: 869.00

Footnotes:

• F1: Payment of fees in deferred share units pursuant to the Hilton 2017 Omnibus Incentive Plan. Each deferred share unit represents one share of Issuer common stock and is fully vested. The underlying shares will be issued to the reporting person upon the earlier to occur of a (i) termination of service as a director, (ii) a change in control of the Issuer, and (iii) the second anniversary of the grant date.